{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:17Z","timestamp":1792382897075,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015831","name":"Radius Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bonr.2020.100291","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T13:20:54Z","timestamp":1593177654000},"page":"100291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice"],"prefix":"10.1016","volume":"13","author":[{"given":"Heike","family":"Arlt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Mullarkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Ominsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Mitlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Lanske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Besschetnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2020.100291_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1006\/dbio.1996.0104","article-title":"Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development","volume":"175","author":"Amizuka","year":"1996","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bonr.2020.100291_bb0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00223-016-0171-1","article-title":"Six weeks of daily abaloparatide treatment increased vertebral and femoral bone mineral density, microarchitecture and strength in ovariectomized osteopenic rats","volume":"99","author":"Bahar","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2020.100291_bb0015","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/17453674.2018.1523771","article-title":"Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models","volume":"89","author":"Bernhardsson","year":"2018","journal-title":"Acta Orthop."},{"key":"10.1016\/j.bonr.2020.100291_bb0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2019.04.025","article-title":"Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis","volume":"124","author":"Besschetnova","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2020.100291_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2018.10.012","article-title":"Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption","volume":"120","author":"Chandler","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2020.100291_bb0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/clinchem\/46.3.431a","article-title":"Circadian variation in serum CrossLaps concentration is reduced in fasting individuals","volume":"46","author":"Christgau","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bonr.2020.100291_bb0035","first-page":"S540","article-title":"BIM-44058, a novel analog of PTHrP with enhanced bone building activity, but decreased calcium-mobilization potential","volume":"16","author":"Culler","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2020.100291_bb0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2020.100291_bb0045","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00198-017-4323-6","article-title":"Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption","volume":"29","author":"Doyle","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2020.100291_bb0050","doi-asserted-by":"crossref","first-page":"16196","DOI":"10.1038\/s41598-019-51720-w","article-title":"Bone anabolic response in the calvaria following mild traumatic brain injury is mediated by the cannabinoid-1 receptor","volume":"9","author":"Eger","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bonr.2020.100291_bb0055","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bone.2009.07.091","article-title":"Rapid and robust response of biochemical markers of bone formation to teriparatide therapy","volume":"45","author":"Glover","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2020.100291_bb0060","first-page":"106","article-title":"Abaloparatide","volume":"13","author":"Gonnelli","year":"2016","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.1016\/j.bonr.2020.100291_bb0065","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/gerona\/glt046","article-title":"The relevance of mouse models for investigating age-related bone loss in humans","volume":"68","author":"Jilka","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bonr.2020.100291_bb0070","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1210\/endo.142.10.8437","article-title":"OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats","volume":"142","author":"Kostenuik","year":"2001","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.bonr.2020.100291_bb0075","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/jbmr.3930","article-title":"Abaloparatide at the same dose has the same effects on bone as PTH (1-34) in mice","volume":"35","author":"Le Henaff","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bonr.2020.100291_bb0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/jc.2014-3718","article-title":"Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis","volume":"100","author":"Leder","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2020.100291_bb0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2009.06.011","article-title":"Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin","volume":"45","author":"Li","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2020.100291_bb0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00223-018-0422-4","article-title":"Abaloparatide exerts bone anabolic effects with less stimulation of bone resorption-related factors: a comparison with teriparatide","volume":"103","author":"Makino","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2020.100291_bb0095","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1172\/JCI26239","article-title":"Osteoblast-derived PTHrP is a physiological regulator of bone formation","volume":"115","author":"Martin","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bonr.2020.100291_bb0100","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/en.2003-1097","article-title":"Skeletal abnormalities in PTH-null mice are influenced by dietary calcium","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bonr.2020.100291_bb0105","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1210\/en.2003-1695","article-title":"Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bonr.2020.100291_bb0110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.bonr.2020.100291_bb0115","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1359\/jbmr.091108","article-title":"Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment","volume":"25","author":"Moore","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2020.100291_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bone.2016.11.004","article-title":"Effects of abaloparatide-SC (BA058) on bone histology and histomorphometry: the ACTIVE phase 3 trial","volume":"97","author":"Moreira","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2020.100291_bb0125","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1359\/jbmr.1999.14.9.1478","article-title":"A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1\u03b2, TNF-\u03b1, PTH, PTHrP, and 1,25(OH)2D3","volume":"14","author":"Morony","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2020.100291_bb0130","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1210\/en.2004-1583","article-title":"The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy","volume":"146","author":"Morony","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bonr.2020.100291_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/8756-3282(94)00033-V","article-title":"The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model","volume":"16","author":"Mosekilde","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2020.100291_bb0140","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","article-title":"Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines","volume":"275","author":"Nakashima","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bonr.2020.100291_bb0145","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bonr.2020.100291_bb0150","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00198-018-4445-5","article-title":"Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study","volume":"29","author":"Paggiosi","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2020.100291_bb0155","doi-asserted-by":"crossref","first-page":"29809","DOI":"10.1074\/jbc.M113.485938","article-title":"Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes","volume":"288","author":"Rhee","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bonr.2020.100291_bb0160","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.1074\/jbc.RA118.004751","article-title":"Parathyroid hormone(1-34) and its analogs differentially modulate osteoblastic Rankl expression via PKA\/SIK2\/SIK3 and PP1\/PP2A-CRTC3 signaling","volume":"293","author":"Ricarte","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bonr.2020.100291_bb0165","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14225","article-title":"Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and \u0392-arrestin recruitment than teriparatide","volume":"7","author":"Sahbani","year":"2019","journal-title":"Physiol Rep"},{"key":"10.1016\/j.bonr.2020.100291_bb0170","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1359\/JBMR.040112","article-title":"Teriparatide [PTH-(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity","volume":"19","author":"Sato","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2020.100291_bb0175","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jcb.22454","article-title":"Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells","volume":"109","author":"Shinoda","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bonr.2020.100291_bb0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bonr.2020.100291_bb0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bone.2016.11.027","article-title":"One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats","volume":"95","author":"Varela","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2020.100291_bb0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jbmr.3003","article-title":"One year of abaloparatide, a selective activator of the PTH1 receptor, increased bone formation and bone mass in osteopenic ovariectomized rats without increasing bone resorption","volume":"32","author":"Varela","year":"2017","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187220300516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187220300516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:20:33Z","timestamp":1762446033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187220300516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":38,"alternative-id":["S2352187220300516"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2020.100291","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2020.100291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Radius Health Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100291"}}